|
[1]
|
Roth, G.A., Mensah, G.A., Johnson, C.O., Addolorato, G., Ammirati, E., Baddour, L.M., et al. (2020) Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019: Update from the GBD 1990-2019 Study. Journal of the American College of Cardiology, 76, 2982-3021. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Mach, F., Baigent, C., Catapano, A.L., Koskinas, K.C., Casula, M., Badimon, L., et al. (2020) 2019 ESC/EAS Guidelines for the Management of Dyslipidaemias: Lipid Modification to Reduce Cardiovascular Risk. European Heart Journal, 41, 111-188. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Sabouret, P., Lpc, F., Bordenave, L., et al. (2021) Residual Cardiovascular Risk: Definition, Clinical Relevance, and Therapeutic Perspectives. Current Medical Research and Opinion, 37, 321-332.
|
|
[4]
|
Ridker, P.M. (2016) From C-Reactive Protein to Interleukin-6 to Interleukin-1: Moving Upstream to Identify Novel Targets for Atheroprotection. Circulation Research, 118, 145-156. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Khera, A.V., Won, H.H., Peloso, G.M., Lawson, K.S., Bartz, T.M., Deng, X., et al. (2016) Diagnostic Yield and Clinical Utility of Sequencing Familial Hypercholesterolemia Genes in Patients with Severe Hypercholesterolemia. Journal of the American College of Cardiology, 67, 2578-2589. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Min, J.K. (2021) Effect of Achieved Low-Density Lipoprotein Cholesterol Level on Residual Cardiovascular Risk. Current Opinion in Lipidology, 32, 307-315.
|
|
[7]
|
Cheng, K., Chu, C., Lin, T., Lee, K., Sheu, S. and Lai, W. (2015) Lipid Paradox in Acute Myocardial Infarction—The Association with 30-Day In-Hospital Mortality. Critical Care Medicine, 43, 1255-1264. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Emerging Risk Factors Collaboration, Kaptoge, S., Di Angelantonio, E., et al. (2010) C-Reactive Protein Concentration and Risk of Coronary Heart Disease, Stroke, and Mortality: An Individual Participant Meta-Analysis. The Lancet, 375, 132-140.
|
|
[9]
|
Ye, Z., Hu, T., Wang, J., et al. (2022) Systemic Immune-Inflammation Index as a Potential Biomarker of Cardiovascular Diseases: A Systematic Review and Meta-Analysis. Frontiers in Cardiovascular Medicine, 9, 933913. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Sun, W., Chen, Z. and Luo, Y. (2025) Association between Systemic Immune-Inflammation Index and Outcomes of Acute Myocardial Infarction: A Systemic Review and Meta-Analysis. Surgical Infections, 26, 183-194. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Guerrero-Romero, F., Simental-Mendía, L.E., González-Ortiz, M., Martínez-Abundis, E., et al. (2010) The Product of Triglycerides and Glucose, a Simple Measure of Insulin Sensitivity. Comparison with the Euglycemic-Hyperinsulinemic Clamp. The Journal of Clinical Endocrinology & Metabolism, 95, 3347-3351. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Tao, L.C., Xu, J.N., Wang, T.T., et al. (2022) Triglyceride-Glucose Index as a Marker in Cardiovascular Diseases. Cardiovascular Diabetology, 21, Article Number 68. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Sun, C., Hu, L., Li, X., et al. (2024) Triglyceride-Glucose Index’s Link to Cardiovascular Outcomes Post-Percutaneous Coronary Intervention in China: A Meta-Analysis. ESC Heart Failure, 11, 1317-1328. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Hotamisligil, G.S. (2006) Inflammation and Metabolic Disorders. Nature, 444, 860-867. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
中华医学会心血管病学分会, 中华心血管病杂志编辑委员会. 急性ST段抬高型心肌梗死诊断和治疗指南(2019) [J]. 中华心血管病杂志, 2019, 47(10): 766-783.
|
|
[16]
|
中华医学会心血管病学分会, 中华心血管病杂志编辑委员会. 非ST段抬高型急性冠脉综合征诊断和治疗指南(2024) [J]. 中华心血管病杂志, 2024, 52(6): 615-646.
|
|
[17]
|
Yang, Y.L., Wu, C.H., Hsu, P.F., Chen, S., Huang, S., Chan, W.L., et al. (2020) Systemic Immune‐Inflammation Index (SII) Predicted Clinical Outcome in Patients with Coronary Artery Disease. European Journal of Clinical Investigation, 50, e13230. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Zhang, Y., Li, S., Xu, R.X., et al. (2021) Systemic Immune-Inflammation Index Is Associated with Disease Severity and Poor Clinical Outcomes in Patients with Acute Myocardial Infarction. Biomarkers in Medicine, 15, 1303-1314.
|
|
[19]
|
Hu, B., Yang, X., Xu, Y., Sun, Y., Sun, C., Guo, W., et al. (2014) Systemic Immune-Inflammation Index Predicts Prognosis of Patients after Curative Resection for Hepatocellular Carcinoma. Clinical Cancer Research, 20, 6212-6222. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Bonaventura, A., Montecucco, F., Dallegri, F., et al. (2019) Novel Findings in Neutrophil Biology and Their Impact on Cardiovascular Disease. Cardiovascular Research, 115, 1266-1285. https://pubmed.ncbi.nlm.nih.gov/30918936/ [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Chia, S., Nagurney, J.T., Brown, D.F.M., Raffel, O.C., Bamberg, F., Senatore, F., et al. (2009) Association of Leukocyte and Neutrophil Counts with Infarct Size, Left Ventricular Function and Outcomes after Percutaneous Coronary Intervention for St-Elevation Myocardial Infarction. The American Journal of Cardiology, 103, 333-337. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Dhabhar, F.S. (2009) Enhancing versus Suppressive Effects of Stress on Immune Function: Implications for Immunoprotection and Immunopathology. Neuroimmunomodulation, 16, 300-317. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Zouridakis, E.G., Garcia-Moll, X., Kaski, J.C., et al. (2000) Usefulness of the Blood Lymphocyte Count in Predicting Recurrent Instability and Death in Patients with Unstable Angina Pectoris. American Journal of Cardiology, 86, 449-451. [Google Scholar] [CrossRef]
|
|
[24]
|
Gawaz, M., Langer, H. and May, A.E. (2005) Platelets in Inflammation and Atherogenesis. Journal of Clinical Investigation, 115, 3378-3384. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
Jolly, S.S., Shenkman, B., Bhavsar, S., et al. (2009) Systematic Review of the Prognostic Importance of Markers of Systemic Inflammation in Acute Coronary Syndromes. Canadian Journal of Cardiology, 25, 471-478.
|
|
[26]
|
Liu, X., Tan, Z., Huang, Y., et al. (2022) Relationship between the Triglyceride-Glucose Index and Risk of Cardiovascular Diseases and Mortality in the General Population: A Systematic Review and Meta-Analysis. Cardiovascular Diabetology, 21, Article Number 124. [Google Scholar] [CrossRef] [PubMed]
|
|
[27]
|
Liu, H., Wang, L., Wang, H., et al. (2024) The Association of Triglyceride-Glucose Index with Major Adverse Cardiovascular and Cerebrovascular Events after Acute Myocardial Infarction: A Meta-Analysis of Cohort Studies. Nutrition & Diabetes, 14, Article Number: 39. [Google Scholar] [CrossRef] [PubMed]
|
|
[28]
|
Capes, S.E., Hunt, D., Malmberg, K. and Gerstein, H.C. (2000) Stress Hyperglycaemia and Increased Risk of Death after Myocardial Infarction in Patients with and without Diabetes: A Systematic Overview. The Lancet, 355, 773-778. [Google Scholar] [CrossRef] [PubMed]
|
|
[29]
|
Ridker, P.M., Everett, B.M., Thuren, T., MacFadyen, J.G., Chang, W.H., Ballantyne, C., et al. (2017) Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease. New England Journal of Medicine, 377, 1119-1131. [Google Scholar] [CrossRef] [PubMed]
|